| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |